Is 18F-DOPA a valid cardiac sympathetic neuroimaging agent?
Conclusions18F-DOPA does not seem to be a valid cardiac sympathetic neuroimaging agent, although brain18F-DOPA scanning provides a biomarker of Parkinsonism.
Source: Clinical Autonomic Research - Category: Research Source Type: research
More News: Brain | Cardiology | Heart | Neurology | Parkinson's Disease | PET Scan | Reflex Sympathetic Dystrophy | Research